These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

377 related items for PubMed ID: 19501205

  • 1. Comparability of ELISA and toxin neutralization to measure immunogenicity of Protective Antigen in mice, as part of a potency test for anthrax vaccines.
    Parreiras PM, Sirota LA, Wagner LD, Menzies SL, Arciniega JL.
    Vaccine; 2009 Jul 16; 27(33):4537-42. PubMed ID: 19501205
    [Abstract] [Full Text] [Related]

  • 2. Ability of ELISA and a toxin neutralization assay to detect changes in immunogenicity of a recombinant Bacillus anthracis protective antigen vaccine upon storage.
    Domínguez-Castillo RI, Verma A, Amador-Molina JC, Sirota L, Arciniega JL.
    Biologicals; 2013 Mar 16; 41(2):111-4. PubMed ID: 23137818
    [Abstract] [Full Text] [Related]

  • 3. Immunogenicity and tolerance of ascending doses of a recombinant protective antigen (rPA102) anthrax vaccine: a randomized, double-blinded, controlled, multicenter trial.
    Gorse GJ, Keitel W, Keyserling H, Taylor DN, Lock M, Alves K, Kenner J, Deans L, Gurwith M.
    Vaccine; 2006 Aug 14; 24(33-34):5950-9. PubMed ID: 16797805
    [Abstract] [Full Text] [Related]

  • 4. Immunogenicity in mice of anthrax recombinant protective antigen in the presence of aluminum adjuvants.
    Berthold I, Pombo ML, Wagner L, Arciniega JL.
    Vaccine; 2005 Mar 14; 23(16):1993-9. PubMed ID: 15734073
    [Abstract] [Full Text] [Related]

  • 5. Standardized, mathematical model-based and validated in vitro analysis of anthrax lethal toxin neutralization.
    Li H, Soroka SD, Taylor TH, Stamey KL, Stinson KW, Freeman AE, Abramson DR, Desai R, Cronin LX, Oxford JW, Caba J, Pleatman C, Pathak S, Schmidt DS, Semenova VA, Martin SK, Wilkins PP, Quinn CP.
    J Immunol Methods; 2008 Apr 20; 333(1-2):89-106. PubMed ID: 18304568
    [Abstract] [Full Text] [Related]

  • 6. An intranasal vaccine targeting both the Bacillus anthracis toxin and bacterium provides protection against aerosol spore challenge in rabbits.
    Wimer-Mackin S, Hinchcliffe M, Petrie CR, Warwood SJ, Tino WT, Williams MS, Stenz JP, Cheff A, Richardson C.
    Vaccine; 2006 May 01; 24(18):3953-63. PubMed ID: 16530302
    [Abstract] [Full Text] [Related]

  • 7. Monitoring of ELISA-reactive antibodies against anthrax protective antigen (PA), lethal factor (LF), and toxin-neutralising antibodies in serum of individuals vaccinated against anthrax with the PA-based UK anthrax vaccine.
    Grunow R, Porsch-Ozcürümez M, Splettstoesser W, Buckendahl A, Hahn U, Beyer W, Böhm R, Huber M, vd Esche U, Bessler W, Frangoulidis D, Finke EJ.
    Vaccine; 2007 May 04; 25(18):3679-83. PubMed ID: 17287051
    [Abstract] [Full Text] [Related]

  • 8. Feasibility of the use of ELISA in an immunogenicity-based potency test of anthrax vaccines.
    Jiménez-Alberto A, Parreiras P, Castelán-Vega J, Sirota L, Arciniega J.
    Biologicals; 2011 Jul 04; 39(4):236-41. PubMed ID: 21664832
    [Abstract] [Full Text] [Related]

  • 9. Duration of protection of rabbits after vaccination with Bacillus anthracis recombinant protective antigen vaccine.
    Little SF, Ivins BE, Webster WM, Fellows PF, Pitt ML, Norris SL, Andrews GP.
    Vaccine; 2006 Mar 24; 24(14):2530-6. PubMed ID: 16417950
    [Abstract] [Full Text] [Related]

  • 10. [Expression, purification and characterization of the recombinant anthrax protective antigen].
    Xu JJ, Dong DY, Song XH, Ge M, Li GL, Fu L, Zhuang HL, Chen W.
    Sheng Wu Gong Cheng Xue Bao; 2004 Sep 24; 20(5):652-5. PubMed ID: 15973984
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of the immune response induced by a nasal anthrax vaccine based on the protective antigen protein in anaesthetized and non-anaesthetized mice.
    Sloat BR, Cui Z.
    J Pharm Pharmacol; 2006 Apr 24; 58(4):439-47. PubMed ID: 16597361
    [Abstract] [Full Text] [Related]

  • 12. Immunogenicity of a subunit vaccine against Bacillus anthracis.
    Chichester JA, Musiychuk K, de la Rosa P, Horsey A, Stevenson N, Ugulava N, Rabindran S, Palmer GA, Mett V, Yusibov V.
    Vaccine; 2007 Apr 20; 25(16):3111-4. PubMed ID: 17280756
    [Abstract] [Full Text] [Related]

  • 13. Mouse model characterisation for anthrax vaccine development: comparison of one inbred and one outbred mouse strain.
    Flick-Smith HC, Waters EL, Walker NJ, Miller J, Stagg AJ, Green M, Williamson ED.
    Microb Pathog; 2005 Jan 20; 38(1):33-40. PubMed ID: 15652293
    [Abstract] [Full Text] [Related]

  • 14. Efficacious, nontoxigenic Bacillus anthracis spore vaccines based on strains expressing mutant variants of lethal toxin components.
    Mendelson I, Gat O, Aloni-Grinstein R, Altboum Z, Inbar I, Kronman C, Bar-Haim E, Cohen S, Velan B, Shafferman A.
    Vaccine; 2005 Dec 01; 23(48-49):5688-97. PubMed ID: 16039760
    [Abstract] [Full Text] [Related]

  • 15. A recombinant 63-kDa form of Bacillus anthracis protective antigen produced in the yeast Saccharomyces cerevisiae provides protection in rabbit and primate inhalational challenge models of anthrax infection.
    Hepler RW, Kelly R, McNeely TB, Fan H, Losada MC, George HA, Woods A, Cope LD, Bansal A, Cook JC, Zang G, Cohen SL, Wei X, Keller PM, Leffel E, Joyce JG, Pitt L, Schultz LD, Jansen KU, Kurtz M.
    Vaccine; 2006 Mar 06; 24(10):1501-14. PubMed ID: 16271808
    [Abstract] [Full Text] [Related]

  • 16. Protection against anthrax and plague by a combined vaccine in mice and rabbits.
    Ren J, Dong D, Zhang J, Zhang J, Liu S, Li B, Fu L, Xu J, Yu C, Hou L, Li J, Chen W.
    Vaccine; 2009 Dec 09; 27(52):7436-41. PubMed ID: 19635609
    [Abstract] [Full Text] [Related]

  • 17. Comparative vaccine efficacy of different isoforms of recombinant protective antigen against Bacillus anthracis spore challenge in rabbits.
    Ribot WJ, Powell BS, Ivins BE, Little SF, Johnson WM, Hoover TA, Norris SL, Adamovicz JJ, Friedlander AM, Andrews GP.
    Vaccine; 2006 Apr 24; 24(17):3469-76. PubMed ID: 16519970
    [Abstract] [Full Text] [Related]

  • 18. Quantitative anti-PA IgG ELISA; assessment and comparability with the anthrax toxin neutralization assay in goats.
    Ndumnego OC, Crafford J, Beyer W, van Heerden H.
    BMC Vet Res; 2013 Dec 27; 9():265. PubMed ID: 24373579
    [Abstract] [Full Text] [Related]

  • 19. Potentiation of an anthrax DNA vaccine with electroporation.
    Luxembourg A, Hannaman D, Nolan E, Ellefsen B, Nakamura G, Chau L, Tellez O, Little S, Bernard R.
    Vaccine; 2008 Sep 19; 26(40):5216-22. PubMed ID: 18462850
    [Abstract] [Full Text] [Related]

  • 20. [Immunogenicity of the recombinant Bacillus strains with cloned gene of biosynthesis of protective antigen against Bacillus anthracis].
    Mikshis NI, Kudriavtseva OM, Bolothikova MF, Shulepov DV, Novikova LV, Popov IuA, Shchukovskaia TN, Drozdov IG, Kutyrev VV.
    Mol Gen Mikrobiol Virusol; 2007 Sep 19; (3):15-21. PubMed ID: 17886469
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.